Salma M. Aldallal 2023. Ofatumumab as an Emerging Treatment Option for Chronic Lymphocytic Leukaemia Patients. Research Highlights in Disease and Health Research Vol. 2. (Feb. 2023), 10–24. DOI:https://doi.org/10.9734/bpi/rhdhr/v2/9253F.